A case-control teratological study of spiramycin, roxithromycin, oleandomycin and josamycin

Acta Obstetricia et Gynecologica Scandinavica

Volumn 79, Issue 3, 2000, Pages 234-237

  Czeizel, Andrew E ^a   Rockenbauer, Magda ^b   Olsen, Jørn ^b   Sørensen, Henrik T ^b  

^a Torokvesz lejto 32   (Hungary)

^b NONE

Author keywords

Congenital abnormalities; Josamycin; Macrolide antibiotics; Oleandomycin; Pregnancy; Roxithromycin; Spiramycin; Teratogenicity

Indexed keywords

JOSAMYCIN; MACROLIDE; OLEANDOMYCIN; ROXITHROMYCIN; SPIRAMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; CASE CONTROL STUDY; CONGENITAL DISORDER; FEMALE; HUMAN; HUNGARY; MAJOR CLINICAL STUDY; PREGNANCY; PRIORITY JOURNAL; TERATOGENICITY;

ABNORMALITIES, MULTIPLE; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; FEMALE; HUMANS; HUNGARY; INFANT, NEWBORN; JOSAMYCIN; OLEANDOMYCIN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; QUESTIONNAIRES; ROXITHROMYCIN; SPIRAMYCIN;

EID: 0033993905     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0412.2000.079003234.x     Document Type: Article

References (18)

1. Czeizel AE, Rockenbauer M, Olsen J. The use of antibiotics during pregnancy. Eur J Obstet Gynecol Reprod Biol 1998; 81: 1-8.
2. Czeizel AE, Rockenbauer M, Sørensen HT, Olsen J. A population-based case-control teratologic study of oral erythromycin treatment during pregnancy. Reprod Toxicol (in press).
3. Remington JS, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO (eds): Infectious diseases of the fetus and newborn infants. 2nd ed. Philadelphia, WB Saunders, 1983.
4. Friedman JF, Polifka JE. The effect of drugs on the fetus and nursing infant. Baltimore, John Hopkins Univ. Press, 1996.
5. Shepard TH. Catalog of teratogenic agents. 9th ed. Baltimore, John Hopkins Univ. Press, 1998.
6. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. 5th ed. Baltimore, William and Wilkins, 1998.
7. Czeizel AE, Rácz J. Evaluation of drug intake during pregnancy in the Hungarian Case-Control Surveillance of Congenital Anomalies. Teratology 1990; 42: 505-12.
8. Czeizel AE. The first 25 years of the Hungarian Congenital Abnormality Registry. Teratology 1997; 55: 299-305.
9. Czeizel AE, Rockenbauer M. Teratogenic study of doxycycline. Obstet Gynecol 1997; 89: 524-8.
10. Czeizel AE. A population-based case-control teratogenic study of metronidazole. Br J Obstet Gynaecol 1998; 105: 322-7.
11. StataCorp. STATA Statistical Software: Release 4.0 for Windows. Stata Corporation. College Station. Texas, 1997.
12. Desmonts G, Couvreur J. Congenital toxoplasmosis. A prospective study of 378 pregnancies. N Engl J Med 1974; 290: 1110-16.
13. Couvreur J, Desmonts G, Thulliez PH. Prophylaxis of congenital toxoplasmosis. Effects of spiramycin on placental infection. J Antimicrob Chemother 1988; 22 (Suppl B): 193-200.
14. Stray-Pedersen B. Treatment of toxoplasmosis in the pregnant mother and newborn child. Scand J Infect Dis 1992; (Suppl 84): 23-31.
15. Nguyen BT, Stadtsbaeder S. Comparative effects of cotrimoxazole (trimethoprim-sulphamethoxazole) and spiramycin in pregnant mice infected with Toxoplasma gondii (Beverly strain). Br J Pharmacol 1985; 85: 713-16.
16. Heinonen OP, Slone D, Shapiro S. Birth Defects and Drugs in Pregnancy. Littleton, MA, Publ Sciences Group, 1977.
17. Dolgova MA, Sawitskaja TN. Changes in anatomical structure and cell composition of lymph nodes after prenatal action of oleandomycin phosphate. (Russian). Arh Anat Gistol Embriol 1989; 91: 53-60.
18. Oshima T, Iwadare M. Studies of josamycin proprionate. Jpn J Antibiot 1973; 26: 148-53.